TY - JOUR
T1 - Parent and practitioner experiences of opt-out consent in neonatal intensive care
T2 - a mixed methods study within a trial
AU - Mitchell, Tracy
AU - Andrzejewska, Izabela
AU - Battersby, Cheryl
AU - Cole, Christina
AU - Daskalopoulou, Zoe
AU - Dorling, Jon
AU - Gale, Chris
AU - Graham, Michaela
AU - Hubbard, Marie
AU - Hardy, Pollyanna
AU - Hurd, Madeleine
AU - King, Andrew Robert
AU - Manley, Brett James
AU - Murray, David
AU - Nuthall, Elizabeth
AU - O'connor, Heather
AU - Ojha, Shalini
AU - Roberts, Calum T.
AU - Rodriquez, Amy
AU - Roehr, Charles Christoph
AU - Stanbury, Kayleigh
AU - Tume, Lyvonne
AU - Young, Lauren
AU - Woolfall, Kerry
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.
PY - 2026/3
Y1 - 2026/3
N2 - Background: In neonatal trials, verbal opt-out consent has been used to reduce burden on families and make recruitment more efficient and representative. It involves information provision through posters and leaflets before randomisation, and parents can verbally âopt out' of their baby being randomised to the trial. There is limited understanding of how opt-out consent is operationalised in a multicentre neonatal trial, and its acceptability to staff and parents. Objective: To explore views and experiences of verbal opt-out consent in neoGASTRIC, a neonatal randomised trial comparing routine and no routine measurements of gastric contents in preterm babies. Methods: A mixed methods (questionnaires, interviews and focus groups) process evaluation within a trial. Setting: Four UK neonatal units. Participants: 253 participants: 167 staff (149 questionnaires; 18 across two focus groups), 86 parents (85 questionnaires; 15 interviews; 14 took part in both). Results: Parents and staff supported opt-out consent in neoGASTRIC as interventions were viewed as low risk and non-invasive. Parents appreciated an appropriately timed research conversation; only 21% noticed study information banners/posters. Operationalisation of opt-out consent varied in terms of when information was provided and randomisation timing. Women approached during labour or within hours of birth reported feeling overwhelmed and lacking capacity to consider research. Some staff operationalised a modified opt-in approach. Conclusions: An appropriately timed verbal opt-out approach to consent was seen acceptable as proportionate in the neonatal context in a low-risk trial comparing different accepted clinical, non-pharmaceutical, practices. Findings informed neoGASTRIC and will guide approaches to consent in this setting.
AB - Background: In neonatal trials, verbal opt-out consent has been used to reduce burden on families and make recruitment more efficient and representative. It involves information provision through posters and leaflets before randomisation, and parents can verbally âopt out' of their baby being randomised to the trial. There is limited understanding of how opt-out consent is operationalised in a multicentre neonatal trial, and its acceptability to staff and parents. Objective: To explore views and experiences of verbal opt-out consent in neoGASTRIC, a neonatal randomised trial comparing routine and no routine measurements of gastric contents in preterm babies. Methods: A mixed methods (questionnaires, interviews and focus groups) process evaluation within a trial. Setting: Four UK neonatal units. Participants: 253 participants: 167 staff (149 questionnaires; 18 across two focus groups), 86 parents (85 questionnaires; 15 interviews; 14 took part in both). Results: Parents and staff supported opt-out consent in neoGASTRIC as interventions were viewed as low risk and non-invasive. Parents appreciated an appropriately timed research conversation; only 21% noticed study information banners/posters. Operationalisation of opt-out consent varied in terms of when information was provided and randomisation timing. Women approached during labour or within hours of birth reported feeling overwhelmed and lacking capacity to consider research. Some staff operationalised a modified opt-in approach. Conclusions: An appropriately timed verbal opt-out approach to consent was seen acceptable as proportionate in the neonatal context in a low-risk trial comparing different accepted clinical, non-pharmaceutical, practices. Findings informed neoGASTRIC and will guide approaches to consent in this setting.
KW - Ethics
KW - Intensive Care Units, Neonatal
KW - Neonatology
KW - Qualitative research
UR - https://www.scopus.com/pages/publications/105014718398
U2 - 10.1136/archdischild-2025-328693
DO - 10.1136/archdischild-2025-328693
M3 - Article
C2 - 40889884
AN - SCOPUS:105014718398
SN - 1359-2998
VL - 111
SP - F162-F168
JO - Archives of Disease in Childhood: Fetal and Neonatal Edition
JF - Archives of Disease in Childhood: Fetal and Neonatal Edition
IS - 2
ER -